Perceptive Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$3,060,000
+50900.0%
300,000
+28309.1%
0.10%
Q4 2016$6,000
-99.7%
1,056
-99.7%
0.00%
-100.0%
Q3 2016$2,175,000
-52.8%
330,593
-47.3%
0.14%
-56.2%
Q2 2016$4,611,000
+327.3%
626,876
+526.9%
0.32%
+236.8%
Q1 2016$1,079,000
-47.2%
100,000
-29.9%
0.10%
-37.1%
Q4 2015$2,042,000
-86.9%
142,603
-80.8%
0.15%
-75.8%
Q3 2015$15,592,000742,1320.62%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 784,704$5,163,0003.14%
WALL STREET ASSOCIATES 149,343$983,0000.34%
DAFNA Capital Management LLC 38,873$256,0000.18%
Perceptive Advisors 330,593$2,175,0000.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,508,0000.07%
FALCON POINT CAPITAL, LLC 69,135$408,0000.06%
Cormorant Asset Management, LP 50,613$333,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$526,0000.01%
FRANKLIN RESOURCES INC 1,314,700$8,650,0000.01%
PUTNAM INVESTMENTS LLC 215,000$1,415,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders